Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 improves acute liver injury induced by D-galactosamine in rats

Applied Microbiology and Biotechnology

Volumn 98, Issue 12, 2014, Pages 5619-5632

  Lv, Long Xian ^a   Hu, Xin Jun ^a   Qian, Gui Rong ^a   Zhang, Hua ^a   Lu, Hai Feng ^a   Zheng, Bei Wen ^a   Jiang, Li ^a   Li, Lan Juan ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Acute liver injury; Bacterial translocation; Cytokines; D Galactosamine; Lactobacillus; Microbiome

Indexed keywords

AMINO ACIDS; BACILLI; BODY FLUIDS; LACTIC ACID; RATS;

ACUTE LIVER INJURY; BACTERIAL TRANSLOCATION; CYTOKINES; D-GALACTOSAMINE; LACTOBACILLUS; MICROBIOME;

GALACTOSAMINE;

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GALACTOSAMINE; GAMMA INTERFERON; INTERLEUKIN 10; PROBIOTIC AGENT; CYTOKINE;

BACTERIUM; ENZYME ACTIVITY; HISTOLOGY; PROBIOTICS; RODENT; TRANSLOCATION;

ACUTE DISEASE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIAL TRANSLOCATION; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; HISTOPATHOLOGY; ILEUM; INTESTINE FLORA; LACTIC ACID BACTERIUM; LACTOBACILLUS PARACASEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS SALIVARIUS; LIVER FAILURE; LIVER FUNCTION; LIVER INJURY; MICROBIOME; NONHUMAN; NUCLEOTIDE SEQUENCE; PEDIOCOCCUS PENTOSACEUS; PROTEIN BLOOD LEVEL; RAT; ANIMAL; BLOOD; CYTOCHEMISTRY; DRUG-INDUCED LIVER INJURY; GROWTH, DEVELOPMENT AND AGING; LACTOBACILLUS; LIVER; LIVER FUNCTION TEST; PATHOLOGY; PEDIOCOCCUS; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

BACTERIA (MICROORGANISMS); LACTOBACILLUS; LACTOBACILLUS PARACASEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS SALIVARIUS; PEDIOCOCCUS PENTOSACEUS; RATTUS;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; CYTOKINES; DRUG-INDUCED LIVER INJURY; GALACTOSAMINE; HISTOCYTOCHEMISTRY; ILEUM; LACTOBACILLUS; LIVER; LIVER FUNCTION TESTS; PEDIOCOCCUS; PROBIOTICS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME;

EID: 84903821509     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-014-5638-2     Document Type: Article

References (30)

1. Adawi D, Kasravi FB, Molin G, Jeppsson B (1997) Effect of Lactobacillus supplementation with and without arginine on liver damage and bacterial translocation in an acute liver injury model in the rat. Hepatology 25:642-647 (Pubitemid 27106447)
2. Adawi D, Molin G, Jeppsson B (1998) Inhibition of nitric oxide production and the effects of arginine and Lactobacillus administration in an acute liver injury model. Ann Surg 228:748-755 (Pubitemid 30191685)
3. Adawi D, Ahrne S, Molin G (2001) Effects of different probiotic strains of Lactobacillus and Bifidobacterium on bacterial translocation and liver injury in an acute liver injury model. Int J Food Microbiol 70:213-220 (Pubitemid 33016335)
4. Bengmark S (2009) Bio-ecological control of chronic liver disease and encephalopathy. Metab Brain Dis 24:223-236
5. Bernal W, Auzinger G, Dhawan A, Wendon J (2010) Acute liver failure. Lancet 376:190-201
6. Capozzi V, Russo P, Duenas MT, Lopez P, Spano G (2012) Lactic acid bacteria producing B-group vitamins: a great potential for functional cereals products. Appl Microbiol Biotechnol 96:1383-1394
7. Deutschman CS, Cereda M, Ochroch EA, Raj NR (2006) Sepsis-induced cholestasis, steatosis, hepatocellular injury, and impaired hepatocellular regeneration are enhanced in interleukin-6 -/- mice. Crit Care Med 34:2613-2620 (Pubitemid 44413061)
8. Du WB, Li LJ, Huang JR, Yang Q, Liu XL, Li J, Chen YM, Cao HC, Xu W, Fu SZ, Chen YG (2005) Effects of artificial liver support system on patients with acute or chronic liver failure. Transplant Proc 37:4359-4364 (Pubitemid 43016031)
9. Festi D, Vestito A, Mazzella G, Roda E, Colecchia A (2006) Management of hepatic encephalopathy: focus on antibiotic therapy. Digestion 73(Suppl 1):94-101
10. Haro C, Zelaya H, Lazarte S, Alvarez S, Aguero G (2009) Lactobacillus casei: influence on the innate immune response and haemostatic alterations in a liver-injury model. Can J Microbiol 55:648-656
11. Hynonen U, Palva A (2013) Lactobacillus surface layer proteins: structure, function and applications. Appl Microbiol Biotechnol 97:5225-5243
12. Johansson ME, Gustafsson JK, Holmen-Larsson J, Jabbar KS, Xia L, Xu H, Ghishan FK, Carvalho FA, Gewirtz AT, Sjovall H, Hansson GC (2013) Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut 63:281-291
13. Joossens M, Huys G, Cnockaert M, De Preter V, Verbeke K, Rutgeerts P, Vandamme P, Vermeire S (2011) Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 60:631-637
14. Kasravi FB, Adawi D, Molin G, Bengmark S, Jeppsson B (1997) Effect of oral supplementation of Lactobacilli on bacterial translocation in acute liver injury induced by D-galactosamine. J Hepatol 26:417-424 (Pubitemid 27077443)
15. Kirpich IA, McClain CJ (2012) Probiotics in the treatment of the liver diseases. J Am Coll Nutr 31:14-23
16. Lu H, He J, Wu Z, Xu W, Zhang H, Ye P, Yang J, Zhen S, Li L (2013) Assessment of microbiome variation during the perioperative period in liver transplant patients: a retrospective analysis. Microb Ecol 65:781-791
17. Ma S, Dai Y (2011) Principal component analysis based methods in bioinformatics studies. Brief Bioinform 12:714-722
18. McGee RG, Bakens A, Wiley K, Riordan SM, Webster AC (2011) Probiotics for patients with hepatic encephalopathy. Cochrane Database Syst Rev 11, CD008716. doi:10.1002/14651858.CD008716
19. Messaoudi S, Manai M, Kergourlay G, Prevost H, Connil N, Chobert JM, Dousset X (2013) Lactobacillus salivarius: bacteriocin and probiotic activity. Food Microbiol 36:296-304
20. Muyzer G, de Waal EC, Uitterlinden AG (1993) Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl Environ Microbiol 59:695-700 (Pubitemid 23072343)
21. O'Grady J (2012) Liver transplantation for acute liver failure. Best Pract Res Clin Gastroenterol 26:27-33
22. Osman N, Adawi D, Ahrne S, Jeppsson B, Molin G (2007) Endotoxin- and D-galactosamine-induced liver injury improved by the administration of Lactobacillus, Bifidobacterium and blueberry. Dig Liver Dis 39:849-856 (Pubitemid 47215581)
23. Schnabl B (2013) Linking intestinal homeostasis and liver disease. Curr Opin Gastroenterol 29:264-270
24. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28:2731-2739
25. Tranah TH, Vijay GK, Ryan JM, Shawcross DL (2013) Systemic inflammation and ammonia in hepatic encephalopathy. Metab Brain Dis 28:1-5
26. Tsai YT, Cheng PC, Pan TM (2012) The immunomodulatory effects of lactic acid bacteria for improving immune functions and benefits. Appl Microbiol Biotechnol 96:853-862
27. Tunon MJ, Alvarez M, Culebras JM, Gonzalez-Gallego J (2009) An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure. World J Gastroenterol 15:3086-3098
28. Vanhoutte T, Huys G, Brandt E, Swings J (2004) Temporal stability analysis of the microbiota in human feces by denaturing gradient gel electrophoresis using universal and group-specific 16S rRNA gene primers. FEMS Microbiol Ecol 48:437-446 (Pubitemid 38648930)
29. Wang Y, Li Y, Xie J, Zhang Y, Wang J, Sun X, Zhang H (2013) Protective effects of probiotic Lactobacillus casei Zhang against endotoxin- and d-galactosamine-induced liver injury in rats via anti-oxidative and anti-inflammatory capacities. Int Immunopharmacol 15:30-37
30. Wlodzimirow KA, Eslami S, Abu-Hanna A, Nieuwoudt M, Chamuleau RA (2012) Systematic review: acute liver failure - one disease, more than 40 definitions. Aliment Pharmacol Ther 35:1245-1256